טאזוצין 4.5 גרם

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

PIPERACILLIN AS SODIUM 4 G; TAZOBACTAM AS SODIUM 0.5 G

Disponible desde:

NEOPHARM LTD

Código ATC:

J01CR05

formulario farmacéutico:

POWDER FOR SOLUTION FOR INJECTION

Vía de administración:

I.V

Fabricado por:

WYETH LEDERLE S.R.L., ITALY

Grupo terapéutico:

PIPERACILLIN AND ENZYME INHIBITOR

indicaciones terapéuticas:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Fecha de autorización:

2009-12-01